Media Room

For More Information Contact

For Media Inquiries:

Dana Korsen
Phone:
202-334-2183
Fax:
202-334-2843
E-mail:
dkorsen@nas.edu

Mailing Address

The National Academies of Sciences, Engineering, and Medicine

Health and Medicine Division

500 Fifth St, NW
Washington, DC 20001

Selected Filters

    • Topic: Quality and Patient Safety [Remove]

Filter News

News and Announcements

The latest news from HMD, including information about new reports, activities, meetings, and other noteworthy events.


News Release

Health Care Reform and Increased Patient Needs Require Transformation of Nursing Profession
Released: 10/5/2010

Nurses' roles, responsibilities, and education should change significantly to meet the increased demand for care that will be created by health care reform and to advance improvements in America's increasingly complex health system, says a new report from the IOM.

Report at a Glance

  • Accessing Primary Care: Barriers to Nurse Practitioner Practice (HTML)
  • Infographic - The Future of Nursing (JPG, HTML)
  • Press Release (HTML)
  • Report Recommendations (PDF, HTML)
  • Report Brief (PDF, HTML)
  • The Future of Nursing: Focus on Education (PDF, HTML)
  • The Future of Nursing: Focus on Scope of Practice (PDF, HTML)
Reports: Related Reports
Activities: Related Activities

Actions Taken

ACGME Board of Directors Approved New Requirements for Residency Programs

On September 28, 2010, the ACGME Board of Directors approved new requirements for residency programs, including updated standards for resident duty hours, education, and supervision.

Report at a Glance

  • Press Release (HTML)
  • Recommendations (PDF)
  • Report Brief (PDF)
Reports: Related Reports
Activities: Related Activities

News Release

Report Offers FDA A Framework for Evaluating Ethical Issues When Deciding Whether to Require Postmarketing Studies of Drugs
Released: 7/9/2010

A new letter report from the IOM recommends a conceptual framework to help the U.S. Food and Drug Administration evaluate the ethical issues involved in determining whether companies should start or continue clinical trials on approved drugs and in ensuring that these studies are ethically conducted. FDA has recently gained enhanced authority to require drug companies to undertake studies of their products after they are put on the market, which presents the agency with additional challenges.

Report at a Glance

  • Press Release (HTML)
Reports: Related Reports
Activities: Related Activities

News Release

IOM Report Recommends Framework to Evaluate Science Behind Health Claims for Foods and Drugs; Calls for Equal Rigor in Assessing Food Claims and Drug Approvals
Released: 5/12/2010

The U.S. Food and Drug Administration (FDA) should apply the same rigor to evaluating the science behind claims of foods' and nutritional supplements' health benefits as it devotes to assessing medication and medical technology approvals, says the IOM's report Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease.

Report at a Glance

Reports: Related Reports
Activities: Related Activities

Announcement

Nominations Open for the 2010 Lienhard Award and Sarnat Prize

The IOM is now accepting nominations for the Gustav O. Lienhard Award and the Rhoda and Bernard Sarnat International Prize in Mental Health. The Lienhard Award recognizes individuals for outstanding achievement in improving health care services in the United States. The Sarnat Prize recognizes individuals, groups, or organizations for outstanding achievement in improving mental health. Nominations will be accepted through May 7, 2010.

Reports: Related Reports
Activities: Related Activities

News Release

National Vaccine Plan Should Prioritize Efforts to Tackle Unmet Health Needs, More Resources for Safety Research and Communication
Released: 12/11/2009

While vaccines help prevent many diseases in the United States, we lack immunization protection against several serious illnesses, says a new report from the Institute of Medicine that identifies priority areas for updating the National Vaccine Plan.

Report at a Glance

Reports: Related Reports
Activities: Related Activities

Media Advisory

Summary of the Summit on Integrative Medicine Offers Data, Expertise
Released: 11/4/2009

Integrative Medicine and the Health of the Public: A Summary of the 2009 Summit, which was released today, offers a wealth of data and information that can be useful to media interested in following developments taking place in integrative medicine.

Reports: Related Reports
Activities: Related Activities

News Release

Thomas E. Starzl, pioneer of organ transplantation science, receives Institute of Medicine's 2009 Lienhard Award
Released: 10/12/2009

The Institute of Medicine presented the 2009 Gustav O. Lienhard Award to Thomas E. Starzl, Distinguished Service Professor of Surgery and director emeritus of the Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine. The award honors Starzl -- regarded as the "father of modern organ transplantation" -- for his foundational role in pioneering and advancing transplantation science.

Reports: Related Reports
Activities: Related Activities

Actions Taken

The Wellness Community to Establish Cancer Survivorship Research and Training Institute

During a meeting in October 2008, The Wellness Community (TWC), a nonprofit organization providing cancer support, announced it would establish a Cancer Survivorship Research & Training Institute in Philadelphia. In explaining the need for this type of Institute, TWC referenced the Institute of Medicine’s November 2007 report Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs.

Report at a Glance

  • Report Brief for Patients (PDF)
  • Report Brief for Providers (PDF)
Reports: Related Reports
Activities: Related Activities

Actions Taken

FDA Acts on Drug Safety Recommendation in IOM Report

On June 30, 2008, the Food and Drug Administration (FDA) shifted authority on drug safety regulatory issues from the Office of New Drugs (OND) to a shared responsibility between OND and the Office of Surveillance and Epidemiology (OSE) as recommended in the IOM report The Future of Drug Safety: Promoting and Protecting the Health of the Public.

Report at a Glance

  • Report Brief (PDF)
Reports: Related Reports
Activities: Related Activities